UBS Group
HIMS icon

UBS Group’s Hims & Hers Health HIMS Stock Holding History

UBS Group’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.3M Sell
2,660,810
-1,490,828
-36% -$40M 0.01% 1182
2026
Q1 		$86.2M Sell
4,151,638
-397,446
-9% -$9.39M 0.01% 1163
2025
Q4 		$148M Buy
4,549,084
+1,685,054
+59% +$72.2M 0.02% 741
2025
Q3 		$162M Buy
2,864,030
+313,189
+12% +$16M 0.03% 700
2025
Q2 		$127M Buy
2,550,841
+763,261
+43% +$34.5M 0.02% 801
2025
Q1 		$52.8M Buy
1,787,580
+71,348
+4% +$2.65M 0.01% 1431
2024
Q4 		$41.5M Buy
1,716,232
+1,429,118
+498% +$35.4M 0.01% 1619
2024
Q3 		$5.29M Sell
287,114
-16,681
-5% -$299K ﹤0.01% 3012
2024
Q2 		$6.13M Buy
303,795
+137,000
+82% +$2.28M ﹤0.01% 2657
2024
Q1 		$2.58M Sell
166,795
-8,828
-5% -$99.5K ﹤0.01% 3686
2023
Q4 		$1.56M Buy
175,623
+115,412
+192% +$853K ﹤0.01% 4070
2023
Q3 		$379K Sell
60,211
-35,265
-37% -$262K ﹤0.01% 4874
2023
Q2 		$897K Buy
95,476
+46,359
+94% +$460K ﹤0.01% 4341
2023
Q1 		$487K Buy
49,117
+2,828
+6% +$24.8K ﹤0.01% 4709
2022
Q4 		$297K Buy
46,289
+44,276
+2,200% +$252K ﹤0.01% 5139
2022
Q3 		$11K Buy
+2,013
New +$12.1K ﹤0.01% 8295
2022
Q1 		– Sell
-5,406
Closed -$35K – 10508
2021
Q4 		$35K Sell
5,406
-3,499
-39% -$25.3K ﹤0.01% 7226
2021
Q3 		$67K Buy
8,905
+6,624
+290% +$56.1K ﹤0.01% 6106
2021
Q2 		$25K Sell
2,281
-2,369
-51% -$28.2K ﹤0.01% 7105
2021
Q1 		$62K Buy
4,650
+2,431
+110% +$40.7K ﹤0.01% 6338
2020
Q4 		$32K Buy
2,219
+1,583
+249% +$17.6K ﹤0.01% 6575
2020
Q3 		$7K Sell
636
-4,189
-87% -$44.6K ﹤0.01% 7114
2020
Q2 		$49K Buy
+4,825
New +$48.2K ﹤0.01% 5871

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Group's HIMS Position: Q2 2026 in Review

UBS Group reduced its Hims & Hers Health (HIMS) stake by 36% in Q2 2026, selling an estimated $40M and leaving 2,660,810 shares worth $92.3M. The position accounts for 0.01% of the portfolio, ranked #1182.

UBS Group first reported a position in HIMS in Q2 2020 and has held it in 23 quarters since. The position peaked at $162M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • UBS Group held 2,660,810 shares of Hims & Hers Health worth $92.3M as of Q2 2026.
  • UBS Group sold 1,490,828 Hims & Hers Health shares in Q2 2026, an estimated $40M.
  • Hims & Hers Health made up 0.01% of UBS Group's portfolio in Q2 2026, its #1182 holding.
  • UBS Group first reported a position in Hims & Hers Health in Q2 2020 and has held it in 23 quarters since.
  • UBS Group's Hims & Hers Health position peaked at $162M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.